You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Align Technology (ALGN) Outperforming Other Medical Stocks This Year?
Investors focused on the Medical space have likely heard of Align Technology (ALGN - Free Report) , but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.
Align Technology is a member of the Medical sector. This group includes 764 individual stocks and currently holds a Zacks Sector Rank of #10. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. ALGN is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for ALGN's full-year earnings has moved 4.59% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
Based on the most recent data, ALGN has returned 12.28% so far this year. Meanwhile, stocks in the Medical group have lost about 3.41% on average. This means that Align Technology is performing better than its sector in terms of year-to-date returns.
Breaking things down more, ALGN is a member of the Medical - Dental Supplies industry, which includes 23 individual companies and currently sits at #186 in the Zacks Industry Rank. This group has gained an average of 2.57% so far this year, so ALGN is performing better in this area.
Investors with an interest in Medical stocks should continue to track ALGN. The stock will be looking to continue its solid performance.